Related references
Note: Only part of the references are listed.Bbvac: A Live Vaccine Candidate That Provides Long-Lasting Anamnestic and Th17-Mediated Immunity against the Three Classical Bordetella spp.
Monica C. Gestal et al.
MSPHERE (2022)
Pertussis Toxin Promotes Pulmonary Hypertension in an Infant Mouse Model of Bordetella pertussis Infection
Karen M. Scanlon et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
A Cross-Sectional Study Revealing the Emergence of Erythromycin-Resistant Bordetella pertussis Carrying ptxP3 Alleles in China
Xiaoying Wu et al.
FRONTIERS IN MICROBIOLOGY (2022)
Mortality risk factors among hospitalized children with severe pertussis
Tingting Shi et al.
BMC INFECTIOUS DISEASES (2021)
Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice
M. Allison Wolf et al.
INFECTION AND IMMUNITY (2021)
Pertussis (Whooping Cough)
Michael D. Decker et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Virus Coinfection is a Predictor of Radiologically Confirmed Pneumonia in Children with Bordetella pertussis Infection
Wujun Jiang et al.
INFECTIOUS DISEASES AND THERAPY (2021)
Vasoactive intestinal peptide promotes host defense against enteric pathogens by modulating the recruitment of group 3 innate lymphoid cells
Hong Bing Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Mechanism of Immunoregulatory Properties of Vasoactive Intestinal Peptide in the K/BxN Mice Model of Autoimmune Arthritis
Javier Leceta et al.
FRONTIERS IN IMMUNOLOGY (2021)
Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice
Illiassou Hamidou Soumana et al.
EMERGING INFECTIOUS DISEASES (2021)
Emerging macrolide resistance in Bordetella pertussis in mainland China: Findings and warning from the global pertussis initiative
Ye Feng et al.
LANCET REGIONAL HEALTH-WESTERN PACIFIC (2021)
Immunomodulation by vasoactive intestinal peptide is associated with increased survival and growth of Salmonella Typhimurium in mice
Basim Askar et al.
CYTOKINE (2020)
Neuropeptides in gut-brain axis and their influence on host immunity and stress
Pingli Wei et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Integrated Signaling Pathways Mediate Bordetella Immunomodulation, Persistence, and Transmission
M. C. Gestal et al.
TRENDS IN MICROBIOLOGY (2019)
Bordetella bronchiseptica Diguanylate Cyclase BdcA Regulates Motility and Is Important for the Establishment of Respiratory Infection in Mice
Keila Belhart et al.
JOURNAL OF BACTERIOLOGY (2019)
Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis
Dylan T. Boehm et al.
NPJ VACCINES (2019)
Enhancement of immune response against Bordetella spp. by disrupting immunomodulation
Monica C. Gestal et al.
SCIENTIFIC REPORTS (2019)
Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance
Dorji Dorji et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2018)
Adaptation of Bordetella pertussis to the Respiratory Tract
Lucille F. van Beek et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Blood or Serum Exposure Induce Global Transcriptional Changes, Altered Antigenic Profile, and Increased Cytotoxicity by Classical Bordetellae
Monica C. Gestal et al.
FRONTIERS IN MICROBIOLOGY (2018)
Reduction of Pertussis Inflammatory Pathology by Therapeutic Treatment With Sphingosine-1-Phosphate Receptor Ligands by a Pertussis Toxin-Insensitive Mechanism
Ciaran Skerry et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
An Extracellular Polysaccharide Locus Required for Transmission of Bordetella bronchiseptica
Kalyan K. Dewan et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
An update of the global burden of pertussis in children younger than 5 years: a modelling study
Karene Hoi Ting Yeung et al.
LANCET INFECTIOUS DISEASES (2017)
Invasion of Dendritic Cells, Macrophages and Neutrophils by the Bordetella Adenylate Cyclase Toxin: A Subversive Move to Fool Host Immunity
Giorgio Fedele et al.
TOXINS (2017)
Acquisition and loss of virulence-associated factors during genome evolution and speciation in three clades of Bordetella species
Bodo Linz et al.
BMC GENOMICS (2016)
Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study
Breanna Barger-Kamate et al.
CLINICAL INFECTIOUS DISEASES (2016)
Pertussis: Microbiology, Disease, Treatment, and Prevention
Paul E. Kilgore et al.
CLINICAL MICROBIOLOGY REVIEWS (2016)
Sphingosine-1-phosphate Receptor Agonism Reduces Bordetella pertussis-mediated Lung Pathology
Ciaran Skerry et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Efficacy of VIP as Treatment for Bacteria-Induced Keratitis Against Multiple Pseudomonas aeruginosa Strains
Thomas W. Carion et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
CD4+ T cells in HIV infection show increased levels of expression of a receptor for vasoactive intestinal peptide, VPAC2
Hayley Ipp et al.
IMMUNOLOGIC RESEARCH (2014)
The Bordetella bronchiseptica Type III Secretion System Is Required for Persistence and Disease Severity but Not Transmission in Swine
Tracy L. Nicholson et al.
INFECTION AND IMMUNITY (2014)
Therapeutic Efficacy of Stable Analogues of Vasoactive Intestinal Peptide against Pathogens
Jenny Campos-Salinas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Resident Microbiota Affect Bordetella pertussis Infectious Dose and Host Specificity
Laura S. Weyrich et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Mouse and Pig Models for Studies of Natural and Vaccine-Induced Immunity to Bordetella pertussis
Kingston H. G. Mills et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Different Effects of Whole-Cell and Acellular Vaccines on Bordetella Transmission
William E. Smallridge et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
IDENTIFICATION OF A CO2 RESPONSIVE REGULON IN BORDETELLA
Sara E. Hester et al.
CARBON CAPTURE AND STORAGE: CO2 MANAGEMENT TECHNOLOGIES (2014)
Comparative genomics of the classical Bordetella subspecies: the evolution and exchange of virulence-associated diversity amongst closely related pathogens
Jihye Park et al.
BMC GENOMICS (2012)
Effect of VIP on the balance between cytokines and master regulators of activated helper T cells
Rebeca Jimeno et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Involvement of multiple distinct Bordetella receptor proteins in the utilization of iron liberated from transferrin by host catecholamine stress hormones
Sandra K. Armstrong et al.
MOLECULAR MICROBIOLOGY (2012)
A Type VI Secretion System Encoding Locus Is Required for Bordetella bronchiseptica Immunomodulation and Persistence In Vivo
Laura S. Weyrich et al.
PLOS ONE (2012)
Identification of a CO2 Responsive Regulon in Bordetella
Sara E. Hester et al.
PLOS ONE (2012)
The occurrence of Bordetella bronchiseptica in pigs with clinical respiratory disease
Zhanqin Zhao et al.
VETERINARY JOURNAL (2011)
Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review
Dongmei Wu et al.
RESPIRATORY RESEARCH (2011)
The absence of the VPAC(2) receptor does not protect mice from Aspergillus induced allergic asthma
A. E. Samarasinghe et al.
PEPTIDES (2010)
A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation
Markus Hoeltje et al.
FASEB JOURNAL (2009)
Active and Passive Immunizations with Bordetella Colonization Factor A Protect Mice against Respiratory Challenge with Bordetella bronchiseptica
Neelima Sukumar et al.
INFECTION AND IMMUNITY (2009)
Persistent Bordetella bronchiseptica pneumonia in an immunocompetent infant and genetic comparison of clinical isolates with kennel cough vaccine strains
Barbara A. Rath et al.
CLINICAL INFECTIOUS DISEASES (2008)
Pertussis Toxin Inhibits Early Chemokine Production To Delay Neutrophil Recruitment in Response to Bordetella pertussis Respiratory Tract Infection in Mice
Charlotte Andreasen et al.
INFECTION AND IMMUNITY (2008)
Suppression of T-lymphocyte activation and chemotaxis by the adenylate cyclase toxin of Bordetella pertussis
Silvia Rossi Paccani et al.
INFECTION AND IMMUNITY (2008)
Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites
Ikhlas A. El Karim et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Pancreatic VIPomas: Subject review and one institutional experience
Amir A. Ghaferi et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Bordetella iron transport and virulence
Timothy J. Brickman et al.
BIOMETALS (2007)
Vasoactive intestinal peptide stimulates mucus secretion, but nitric oxide has no effect on mucus secretion in the ferret trachea
Jung-Soo Kim et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Epidemiology and susceptibility of pathogenic bacteria responsible for upper respiratory tract infections in pet rabbits
S. Rougier et al.
VETERINARY MICROBIOLOGY (2006)
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies
S Mattoo et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide?
D Pozo et al.
FASEB JOURNAL (2004)
Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica
J Parkhill et al.
NATURE GENETICS (2003)
Bronchodilation by an inhaled VPAC2 receptor agonist in patients with stable asthma
A Lindén et al.
THORAX (2003)
Predictors of death in infants hospitalized with pertussis: A case-control study of 16 pertussis deaths in Canada
LK Mikelova et al.
JOURNAL OF PEDIATRICS (2003)
Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide
EJ Goetzl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Vasoactive intestinal polypeptide as mediator of asthma
DA Groneberg et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
